Glen Eagle Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.39K | Hold |
47
| – | – | ﹤0.01% | 830 |
|
|
2025
Q4 | $1.39K | Hold |
47
| – | – | ﹤0.01% | 927 |
|
|
2025
Q3 | $1.21K | Buy |
47
+10
| +27% | +$279 | ﹤0.01% | 977 |
|
|
2025
Q2 | $1.02K | Hold |
37
| – | – | ﹤0.01% | 934 |
|
|
2025
Q1 | $1.05K | Sell |
37
-22
| -37% | -$781 | ﹤0.01% | 925 |
|
|
2024
Q4 | $2.45K | Hold |
59
| – | – | ﹤0.01% | 846 |
|
|
2024
Q3 | $3.94K | Hold |
59
| – | – | ﹤0.01% | 804 |
|
|
2024
Q2 | $7.01K | Buy |
59
+12
| +26% | +$1.52K | ﹤0.01% | 710 |
|
|
2024
Q1 | $5.01K | Sell |
47
-5
| -10% | -$504 | ﹤0.01% | 764 |
|
|
2023
Q4 | $5.17K | Hold |
52
| – | – | ﹤0.01% | 734 |
|
|
2023
Q3 | $5.37K | Hold |
52
| – | – | ﹤0.01% | 714 |
|
|
2023
Q2 | $6.32K | Sell |
52
-6
| -10% | -$800 | ﹤0.01% | 703 |
|
|
2023
Q1 | $8.91K | Buy |
58
+10
| +21% | +$1.65K | ﹤0.01% | 634 |
|
|
2022
Q4 | $8.62K | Buy |
48
+2
| +4% | +$327 | ﹤0.01% | 639 |
|
|
2022
Q3 | $5.44K | Hold |
46
| – | – | ﹤0.01% | 691 |
|
|
2022
Q2 | $6.57K | Hold |
46
| – | – | ﹤0.01% | 686 |
|
|
2022
Q1 | $7.92K | Hold |
46
| – | – | ﹤0.01% | 661 |
|
|
2021
Q4 | $11.7K | Hold |
46
| – | – | ﹤0.01% | 594 |
|
|
2021
Q3 | $17.7K | Hold |
46
| – | – | 0.01% | 578 |
|
|
2021
Q2 | $10.8K | Hold |
46
| – | – | ﹤0.01% | 680 |
|
|
2021
Q1 | $6.02K | Hold |
46
| – | – | ﹤0.01% | 743 |
|
|
2020
Q4 | $4.81K | Buy |
46
+31
| +207% | +$3.14K | ﹤0.01% | 749 |
|
|
2020
Q3 | $1.06K | Buy |
+15
| New | +$1.05K | ﹤0.01% | 844 |
|
Other funds holding MRNA
VCM
VPM
